Beyond Appetite: How GLP-1 Medications Affect the Gut

GLP-1 receptor agonists (GLP-1RAs) such as Ozempic and Mounjaro are now widely used to help manage diabetes and support weight loss. Many people are familiar with common side effects such as nausea, feeling full quickly, vomiting, and changes in appetite. These effects are mainly linked to the way these medications slow down digestion.

One area that is still not well understood is how GLP-1RAs affect the gut microbiome. The gut microbiome is made up of trillions of microbes that help with digestion, immunity, metabolism, and communication between the gut and the brain. Even though these microbes are important for overall health, we still know very little about how GLP-1RAs may change them. This matters because the microbiome can influence how the body responds to changes, including medications.

How GLP-1 Medications Slow Digestion

GLP-1RAs work by slowing the movement of food from the stomach into the small intestine. This process is called gastric emptying.

When food stays in the stomach for longer, people may feel full sooner and eat less. This can help with blood glucose management and weight loss. However, it can also cause side effects such as nausea, bloating, or vomiting, especially when starting treatment or increasing the dose.

Slower digestion also changes the environment inside the digestive tract. Food stays in the stomach for longer, which can affect factors such as stomach acidity, nutrient delivery, digestive processes, and bile flow. These changes may influence the types of microbes that grow in the gut and how they function.

Why the Gut Microbiome Matters

The gut microbiome does much more than help digest food. It plays an important role in metabolism, immune function, and communication between the gut and the brain.

Microbes are affected by many things, including diet, stress, medications, hydration, and lifestyle habits. GLP-1RAs may also affect the microbiome, although researchers are still learning how.

Early studies suggest that changes in gut motility and bile acids may lead to changes in microbial populations. Microbes may also play a role in how well some people respond to GLP-1RA treatment. However, the research is still in its early stages, and we do not yet have clear answers.

The Link Between the Microbiome and Natural GLP-1

One of the most interesting areas of research is how the microbiome helps the body produce its own GLP-1.

GLP-1 is not only a medication. It is also a hormone that the body naturally releases after eating. This hormone helps regulate appetite, blood glucose levels, and digestion.

Certain gut microbes help increase natural GLP-1 production. They do this by breaking down fibre and producing compounds called short-chain fatty acids, including butyrate and propionate. These compounds help stimulate GLP-1 release. Gut microbes also change bile acids in ways that can support GLP-1 production.

A healthy and balanced microbiome may therefore help support the body's natural GLP-1 system. If GLP-1 medications change the gut environment, they may also affect the microbes involved in this process. More research is needed to understand these connections.

Nutrition Tips to Support Gut Health

Although research is still developing, nutrition remains one of the best ways to support gut health while taking GLP-1RAs.

Fibre is important because it helps feed beneficial gut microbes. However, because digestion is slower on these medications, increasing fibre gradually can help reduce bloating and discomfort.

Staying hydrated is also important, as adequate fluid intake can support digestion and bowel regularity.

Fermented foods such as yoghurt, kefir, and tempeh may help support microbial diversity, although they should be introduced gradually if nausea is an issue.

Many people find that smaller, balanced meals are easier to tolerate than large meals. Including healthy fats from foods such as olive oil, nuts, seeds, and avocado may also support gut function and microbial health.

Gentle sources of fibre, such as ground oats and cooked vegetables, are often well tolerated. Proper chewing of fibre rich foods can also help with the breakdown process and hence be included as part of a well-balanced diet to support the microbiome.

Takeaways

We know that GLP-1 medications slow digestion, but their effects on the gut microbiome are still being explored. What is becoming increasingly clear is that the microbiome plays an important role in natural GLP-1 production, digestion, and overall health.

While we wait for more research, nutrition remains a practical way to support gut health and the microbiome during GLP-1RA treatment. Supporting the gut is about more than managing symptoms; it is about supporting the whole person, and nutrition is an important part of that process.

References

1.     Gofron KK, Wasilewski A, Małgorzewicz S. Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review. Nutrients. 2025;17(8):1303.

2.     Kamath S, Chan NSL, Joyce P. GLP-1 agonists and the gut microbiome: a bidirectional relationship. Br J Clin Pharmacol. 2026;92(5):1309-1325.

3.     Johnson AJ, O'Sullivan EN, Valyasevi P, Metras B, Jang S, Shields-Cutler R, et al. The potential for complex interplay between GLP-1 receptor agonists, gut microbiome, and obesity management. Can J Physiol Pharmacol. 2026;104:1-8. doi:10.1139/cjpp-2025-0219.

4.     Fogelson KA, Dorrestein PC, Zarrinpar A, Knight R. The gut microbial bile acid modulation and its relevance to digestive health and diseases. Gastroenterology. 2023;164(7):1069-1085.

5.     De La Motte LR, Carreras F, Drago L. The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review. Front Endocrinol.